1,4-Dichloro-2-fluoro-5-nitrobenzene, 5g

4-Methoxybenzyl 2,2,2-trichloroacetimidate, 95.0%, 10g

Ethyl (2,4-dimethylbenzoyl)acetate, 97.0%, 500mg

2-Bromovaleric acid, 98.0%, 25g

Methyl 2-hydroxy-4-methylbenzoate, 95.0%, 100g

tert-Butyl (5-nitropyridin-2-yl)carbamate, 95.0%, 1g

N-(2-aminoethyl)nicotinamide dihydrochloride, 95.0%, 1g

4-(4-Methyl-2-pyridyl)benzonitrile, 97.0%, 2g

Diethyl 2-methylenesuccinate (stabilised with TBC), 95.0%, 500g

2-Ethynyl-4-nitropyridine, 97%, 250mg

Plaques HPTLC RP-18 W / UV254 - modifiées par octadécyle, 20 x 20 cm, 1,00 mm, 15 pièce(s)

Colonne en polypropylène SPE CHROMABOND® C18 ec, 3 ml, 500 mg, 50 pièce(s)

Solution ATP